TS
EW icon

Triglav Skladi’s Edwards Lifesciences EW Stock Holding History

Triglav Skladi’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Hold
18,060
– – 0.1% 107
2025
Q4 		$1.54M Sell
18,060
-2,000
-10% -$164K 0.1% 106
2025
Q3 		$1.56M Hold
20,060
– – 0.1% 91
2025
Q2 		$1.57M Hold
20,060
– – 0.11% 90
2025
Q1 		$1.45M Hold
20,060
– – 0.12% 88
2024
Q4 		$1.49M Buy
+20,060
New +$1.4M 0.12% 88

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Triglav Skladi's EW Position: Q1 2026 in Review

Triglav Skladi held its Edwards Lifesciences (EW) position steady in Q1 2026 at 18,060 shares worth $1.45M. The position accounts for 0.1% of the portfolio, ranked #107.

Triglav Skladi first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.57M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Triglav Skladi held 18,060 shares of Edwards Lifesciences worth $1.45M as of Q1 2026.
  • Triglav Skladi left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.1% of Triglav Skladi's portfolio in Q1 2026, its #107 holding.
  • Triglav Skladi first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • Triglav Skladi's Edwards Lifesciences position peaked at $1.57M in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.